Trial Profile
Efficacy and Safety of Ingenol Mebutate Gel 0.015% Compared to Diclofenac Sodium Gel 3% in Subjects With Actinic Keratoses on the Face or Scalp
Status:
Completed
Phase of Trial:
Phase IV
Latest Information Update: 14 Jul 2021
Price :
$35
*
At a glance
- Drugs Ingenol mebutate (Primary) ; Diclofenac
- Indications Actinic keratosis
- Focus Therapeutic Use
- Sponsors LEO Pharma
- 01 Jun 2021 Results evaluating distinct subgroup of patients with AK might respond better to treatment with ingenol mebutate (IngMeb) versus diclofenac sodium (DS) published in the Journal of Dermatological Treatment
- 14 Oct 2017 Primary endpoint (Complete clearance of all AKs) has been met as per the results published in the British Journal of Dermatology
- 14 Oct 2017 Results published in the British Journal of Dermatology